Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
5.95
-0.04 (-0.67%)
At close: Apr 28, 2026, 4:00 PM EDT
6.20
+0.25 (4.20%)
Pre-market: Apr 29, 2026, 8:10 AM EDT

Plus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
4170781116
Upgrade
Market Cap Growth
221.49%938.30%-14.33%-25.69%-33.96%67.05%
Upgrade
Enterprise Value
336051-42
Upgrade
Last Close Price
5.9512.8128.7543.75118.87393.75
Upgrade
PS Ratio
7.8313.511.161.6147.55-
Upgrade
PB Ratio
8.2617.62-0.76-5.871.651.49
Upgrade
P/TBV Ratio
12.4121.39--1.781.55
Upgrade
EV/Sales Ratio
6.3411.550.930.30--
Upgrade
Debt / Equity Ratio
0.210.21-0.38-3.100.880.65
Upgrade
Net Debt / Equity Ratio
-1.95-1.950.033.24-1.94-1.05
Upgrade
Net Debt / EBITDA Ratio
0.530.530.020.350.650.97
Upgrade
Net Debt / FCF Ratio
0.370.370.020.340.931.09
Upgrade
Asset Turnover
0.450.450.650.280.01-
Upgrade
Quick Ratio
0.730.730.270.801.533.14
Upgrade
Current Ratio
1.231.230.340.921.843.36
Upgrade
Return on Equity (ROE)
----522.50%-234.65%-193.25%
Upgrade
Return on Assets (ROA)
-83.29%-83.29%-101.93%-47.23%-53.74%-44.65%
Upgrade
Return on Capital Employed (ROCE)
-381.40%-381.40%164.80%-2015.30%-164.10%-75.60%
Upgrade
Earnings Yield
-54.83%-31.80%-191.39%-168.24%-190.35%-83.08%
Upgrade
FCF Yield
-51.05%-29.60%-157.80%-164.38%-126.56%-64.63%
Upgrade
Buyback Yield / Dilution
-910.35%-910.35%-145.18%-79.45%-117.18%-173.02%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.